amiloride has been researched along with Bile Duct Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alpini, G; Alvaro, D; Benedetti, A; DeMorrow, S; Francis, H; Glaser, S; LeSage, G; Mancino, MG; Marucci, L; Ueno, Y; Venter, J | 1 |
1 other study(ies) available for amiloride and Bile Duct Diseases
| Article | Year |
|---|---|
The alpha2-adrenergic receptor agonist UK 14,304 inhibits secretin-stimulated ductal secretion by downregulation of the cAMP system in bile duct-ligated rats.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Amiloride; Animals; Anti-Arrhythmia Agents; Bicarbonates; Bile; Bile Duct Diseases; Bile Ducts, Intrahepatic; Brimonidine Tartrate; Chloride-Bicarbonate Antiporters; Chlorides; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Down-Regulation; Hepatocytes; Ligation; Liver; Male; Quinoxalines; Rats; Rats, Inbred F344; Receptors, Adrenergic, alpha-2; Secretin; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Yohimbine | 2007 |